Skip to main content
ScienceWhys: Questions at the Confluence of Science and Ethics

ScienceWhys: Questions at the Confluence of Science and Ethics

By Nobel Conference
When big scientific questions meet big ethical questions, the waters can get pretty choppy. Lisa Heldke, philosopher and director of the Nobel Conference at Gustavus Adolphus College, interviews scientists, researchers, scholars and thinkers about how science and ethics mingle, eddy, roil and churn in their own work. The podcast for anyone who hears about a scientific breakthrough and thinks “what are the downstream consequences of that?”
Listen on
Where to listen
Breaker Logo

Breaker

Google Podcasts Logo

Google Podcasts

Pocket Casts Logo

Pocket Casts

RadioPublic Logo

RadioPublic

Spotify Logo

Spotify

My Research is Applying Data Analysis to Get Some Signal in the Chaos Which is Cancer Biology
Bissan Al-Lazikani, head of data science, computational biology and chemogenomics at the Institute of Cancer Research, London, explains how she and her colleagues developed the CanSAR “knowledgebase”--a database that puts together myriad types of data from anonymous cancer patient records, in order to improve the odds of successfully discovering new cancer drugs.
1:09:23
October 1, 2020
I Work Diligently and Excitedly to Bring Different Groups Together to Work Towards Solving a Complex Problem Related to Health Care Outcomes, Particularly Among Minority Populations
Chanita Hughes-Halbert, Associate Dean for Assessment and Evaluation and Professor of Psychiatry and Behavioral Sciences at the Medical University of South Carolina.
1:01:11
September 28, 2020
No One Before Has Actually Assessed the Psychological Impact of Prostate Cancer on Men
Suzanne Chambers, Dean of the Faculty of Health, University of Sydney, discusses her indirect path to becoming a clinical psychologist studying the impact of prostate cancer on men and their families, and the book she has written for men diagnosed with prostate cancer, Facing the Tiger.
1:06:27
September 21, 2020
With Genetic Engineering, You Can Induce the Cells to Make the Drugs For You
James Thomas, Executive Vice President, Global Head of Biotherapeutics, President of U.S. Operations for Just-Evotec Biologics, explains how the cost of biologically derived drugs has been reduced during the first thirty years of their development, and talks about what it will take to bring those costs down another order of magnitude.
1:05:24
September 17, 2020
The Conductor of the Orchestra of Our Immune System is T cells, and at the Heart of What I Do For Cancer Therapy is Making T Cells Work Better
Carl June, Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine, Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine, and Director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania.
1:06:16
September 14, 2020
My Population is Cancer Patients, My Intervention is Exercise and My Outcomes Vary
Kathryn Schmitz, Professor of Public Health Sciences, and Behavioral Research Professor in Physical Medicine and Rehabilitation at the Penn State Cancer Institute, reflects on the growing body of evidence that supports the use of exercise as medicine in the treatment of cancer...and the reluctance of clinicians to prescribe exercise for their patients with cancer.
1:01:21
September 7, 2020
I Want to Solve Puzzles, and the Puzzles I’m Most Interested in Involve Cancer
Charles Sawyers, chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, talks about his path to becoming a biomedical researcher, his role in the development of Glevec, the first molecularly targeted cancer therapy, and Project GENIE, the cancer research database he launched.
1:06:45
September 2, 2020
Welcome to ScienceWhys: Questions at the Confluence of Science and Ethics
When big scientific questions meet big ethical questions, the waters can get pretty choppy. Lisa Heldke, philosopher and director of the Nobel Conference at Gustavus Adolphus College, interviews scientists, researchers, scholars and thinkers about how science and ethics mingle, eddy, roil and churn in their own work. The podcast for anyone who hears about a scientific breakthrough and thinks “what are the downstream consequences of that?”
03:39
September 1, 2020